miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2

被引:45
|
作者
Huang, Weizhen [1 ]
Li, Jun [1 ]
Guo, Xiaohong [1 ]
Zhao, Yingchu [2 ]
Yuan, Xia [1 ]
机构
[1] Huizhou Municipal Cent Hosp Guangdong Prov, Dept Med Oncol, 41 North Eling Rd, Huizhou 516000, Guangdong, Peoples R China
[2] Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA
关键词
Hepatocellular carcinoma; miR-663a; HMGA2; NONCODING RNA; MESENCHYMAL TRANSITION; BETA-CATENIN; TUMOR-GROWTH; PROMOTES; METASTASIS; EXPRESSION; OVEREXPRESSION; BIOMARKERS; MICRORNAS;
D O I
10.1016/j.biopha.2016.04.034
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatocellular carcinoma (HCC) is a highly aggressive solid malignancy throughout the world. Dysregulation of miRNAs play essential roles in HCC progression via aberrant regulation of cell proliferation, apoptosis, as well as metastasis. miR-663a is a poorly investigated miRNA. Whether miR-663a regulates HCC development remains unknown. The aim of the study was to explore the role of miR-663a in HCC development. To determine the expression level of miR-663a in HCC, we analyzed the data from GSE21362 and TCGA. The results showed that miR-663a was significantly down-regulated in HCC tissue compared with adjacent non-tumor tissue. Gain of function and loss of function assays revealed that miR-663a distinctly inhibited cell proliferation, migration and invasion. Mechanistic investigations demonstrated that miR-663a modulated cell functions through targeting and suppressing high mobility group A2 (HMGA2). In addition, overexpression of HMGA2 remarkably attenuated the tumor repressive effect of miR-663a. Taken together, miR-663a inhibits HCC cell proliferation and motility by targeting HMGA2. (C) 2016 Published by Elsevier Masson SAS.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 50 条
  • [1] miR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2
    Liu, Yu
    Liang, Hongyan
    Jiang, Xiaofeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (05) : 1345 - 1352
  • [2] MiR-497 inhibits cell proliferation and invasion ability by targeting HMGA2 in pancreatic ductal adenocarcinoma
    Zhou, Z-G
    Xu, C.
    Dong, Z.
    Wang, Y-P
    Duan, J-Y
    Yan, C-Q
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (01) : 122 - 129
  • [3] miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma
    Zhang, Chengshuo
    Chen, Baomin
    Jiao, Ao
    Li, Feng
    Sun, Ning
    Zhang, Guoqing
    Zhang, Jialin
    BMC CANCER, 2018, 18
  • [4] miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma
    Chengshuo Zhang
    Baomin Chen
    Ao Jiao
    Feng Li
    Ning Sun
    Guoqing Zhang
    Jialin Zhang
    BMC Cancer, 18
  • [5] miR-150 represses metastasis of hepatocellular carcinoma by targeting HMGA2
    Liu, Xiaoying
    Liu, Yuan
    Ye, Suiyan
    Gong, Yanwei
    Fan, Haiyan
    Miao, Lingli
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 13836 - 13843
  • [6] miR-760 mediated the proliferation and metastasis of hepatocellular carcinoma cells by regulating HMGA2
    Wang, Quhui
    Wang, Gang
    Xu, Xiaodong
    Chen, Zhong
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 222
  • [7] TARGETING THE EPIGENETIC MODIFIER HMGA2 IN DIPG AND HIGH GRAND GLIOMAS INHIBITS PROLIFERATION, INVASION AND TUMORIGENICITY
    Kaur, Harpreet
    Guo, Huizi
    Akhtarkhavari, Sepehr
    Eberhart, Charles
    Raabe, Eric
    NEURO-ONCOLOGY, 2019, 21 : 92 - 92
  • [8] MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2
    Li, Hesheng
    Sun, Qinglei
    Han, Bing
    Yu, Xingquan
    Hu, Baoguang
    Hu, Sanyuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 4782 - 4790
  • [9] MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
    Wenjing Li
    Jun Li
    Hong Mu
    Meiqi Guo
    Haixia Deng
    Cancer Cell International, 19
  • [10] MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
    Li, Wenjing
    Li, Jun
    Mu, Hong
    Guo, Meiqi
    Deng, Haixia
    CANCER CELL INTERNATIONAL, 2019, 19 (1)